Norman Schwartz Net Worth

Norman Schwartz biography

Norman D. Schwartz is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Schwartz has been our President and Chief Executive Officer since 2003 and our Chairman of the Board since 2012. He was our Vice President from 1989 to 2002, our Group Manager, Life Science, from 1997 to 2002 and our Group Manager, Clinical Diagnostics, from 1993 to 1997.

What is the salary of Norman Schwartz?

As the Chairman of the Board, President e Chief Executive Officer of Bio-Rad Laboratories, the total compensation of Norman Schwartz at Bio-Rad Laboratories is $7,261,050. There are no executives at Bio-Rad Laboratories getting paid more.

How old is Norman Schwartz?

Norman Schwartz is 70, he's been the Chairman of the Board, President e Chief Executive Officer of Bio-Rad Laboratories since 2012. There are 3 older and 18 younger executives at Bio-Rad Laboratories. The oldest executive at Bio-Rad Laboratories Inc. is Alice Schwartz, 93, who is the Director.

What's Norman Schwartz's mailing address?

Norman's mailing address filed with the SEC is Alfred Nobel Drive, Hercules, Contra Costa County, California, 94547, United States of America.

What does Bio-Rad Laboratories do?

bio-rad laboratories (nyse: bio and biob) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. founded in 1952, bio-rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. throughout its existence, bio-rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. based in hercules, ca, bio-rad has operations worldwide.

Bio-Rad Laboratories executives and stock owners

Bio-Rad Laboratories executives and other stock owners filed with the SEC include:

• Norman Schwartz,
  Chairman of the Board, President, Chief Executive Officer
• Norman D. Schwartz,
  Chairman, CEO & Pres
• Andrew Last,
  Chief Operating Officer, Executive Vice President
• Ilan Daskal,
  Chief Financial Officer, Executive Vice President
• Annette Tumolo,
  Executive Vice President, President, Life Science Group
• Michael Crowley,
  Executive Vice President - Global Commercial Operations
• Dr. Andrew J. Last,
  Exec. VP & COO
• Dara Grantham Wright,
  Exec. VP & Pres of Clinical Diagnostics Group
• Ilan Daskal,
  Exec. VP & CFO
• Giovanni Magni,
  Executive Vice President, Chief Strategy Officer
• Gregory Hinckley,
  Lead Independent Director
• Melinda Litherland,
  Independent Director
• Jeffrey Edwards,
  Independent Director
• Arnold Pinkston,
  Independent Director
• Alice Schwartz,
  Director
• Ronald Hutton,
  Vice President, Treasurer
• Ajit Ramalingam,
  Senior Vice President, Chief Accounting Officer
• Dara Wright,
  Executive Vice President and President of the Clinical Diagnostics Group
• Timothy Ernst,
  Executive Vice President, General Counsel, Secretary
• Michael Crowley,
  Exec. VP of Global Commercial Operations
• Colleen Corey,
  Sr. VP of Global HR
• Timothy S. Ernst,
  Exec. VP, Gen. Counsel & Sec.
• Yong Chung,
  VP of Investor Relations
• Diane Dahowski,
  Sr. VP of Global Technology & Systems
• Ajit Ramalingam,
  Sr. VP & Chief Accounting Officer
• John Goetz,
  Group Manager - CDG
• Bradford Crutchfield,
  Vice President
• James Bennett,
  Director
• James R Stark,
  Corporate Controller
• Christine A Tsingos,
  Chief Financial Officer
• David Schwartz,
  Director
• Sanford Wadler,
  Secretary
• Naumann Ruediger Etienne,
  Director
• Ruediger Naumann Etienne,
  Director